Methods for treating pigmentary and vascular abnormalities in a dermal region
View Patent ↗A beam of radiation can be provided to treat a dermatological condition in a target region of skin. The beam of radiation can have a wavelength between about 700 nm and about 800 nm, a fluence greater than about 50 J/cm 2 , and a pulse duration between about 10 msec and about 300 msec. The beam of radiation is delivered to the target region of skin to affect (i) at least one pigmentary abnormality disposed in an epidermal region of the target region and (ii) at least one vascular abnormality disposed in a dermal region of the target region. A surface of the epidermal region of the target region of skin can be cooled to prevent substantial unwanted injury to at least a portion of the epidermal region.
1. A method of treating a pigmentary abnormality disposed in an epidermal region and a vascular abnormality disposed in a dermal region of a target region of skin, comprising:
providing a beam of radiation having a wavelength between about 700 nm and about 800 nm, a fluence greater than about 50 J/cm 2 , and a pulse duration between about 10 msec and about 300 msec;
delivering, during a single pass of a delivery device, the beam of radiation to the target region of skin to affect (i) at least one pigmentary abnormality disposed in the epidermal region of the target region and (ii) at least one vascular abnormality disposed in the dermal region of the target region; and
cooling a surface of the epidermal region of the target region of skin.
2. The method of claim 1 further comprising providing a dynamic cooling device to cool the epidermal region of the target region of skin.
3. The method of claim 1 wherein at least one pigmentary abnormality and at least one vascular abnormality are treated substantially simultaneously.
4. The method of claim 1 further comprising positioning, over the target region of skin, a delivery device capable of directing the beam of radiation to the target region of skin.
5. The method of claim 4 further comprising traversing the beam of radiation along the surface of the target region of skin to treat the at least one vascular abnormality and the at least one pigmentary abnormality during a single pass of the delivery device.
6. The method of claim 1 wherein the beam of radiation has a fluence of between about 60 J/cm 2 and about 300 J/cm 2 .
7. The method of claim 1 wherein the beam of radiation has a fluence of between about 60 J/cm 2 and about 150 J/cm 2 .
8. The method of claim 1 wherein the beam of radiation has a fluence of between about 80 J/cm 2 and about 100 J/cm 2 .
9. The method of claim 1 wherein the beam of radiation has a wavelength of about 755 nm.
10. The method of claim 1 wherein the beam of radiation has a pulse duration between about 20 msec and about 60 msec.
11. The method of claim 1 wherein the beam of radiation has a wavelength of about 755 nm, a fluence of between about 80 J/cm 2 and about 100 J/cm 2 , and a pulse duration between about 20 msec and about 60 msec.
12. The method of claim 1 wherein the vascular abnormality includes a blood vessel having a diameter of less than about 1.5 mm, the fluence is greater than about 100 J/cm 2 , and the spotsize is less than about 5 mm.
13. The method of claim 1 wherein the target region of skin is disposed on a patient's face.
14. The method of claim 1 further comprising providing an alexandrite laser source to provide the beam of radiation having a wavelength at about 755 nm.
15. A method of treating a pigmentary abnormality disposed in an epidermal region and a vascular abnormality disposed in a dermal region of a target region of skin, comprising:
providing a beam of radiation having a wavelength between about 700 nm and about 800 nm, a fluence of between about 80 J/cm 2 and about 100 J/cm 2 , and a pulse duration between about 20 msec and about 60 msec;
delivering, during a single pass of a delivery device, the beam of radiation to the target region of skin to affect (i) at least one pigmentary abnormality disposed in the epidermal region of the target region and (ii) at least one vascular abnormality disposed in the dermal region of the target region; and
cooling a surface of the epidermal region of the target region of skin.
16. The method of claim 15 further comprising providing a dynamic cooling device to cool the epidermal region of the target region of skin.
17. The method of claim 15 wherein at least one pigmentary abnormality and at least one vascular abnormality are treated substantially simultaneously.
18. The method of claim 15 further comprising positioning, over the target region of skin, a delivery device capable of directing the beam of radiation to the target region of skin.
19. The method of claim 18 further comprising traversing the beam of radiation along the surface of the target region of skin to treat the at least one vascular abnormality and the at least one pigmentary abnormality during a single pass of the delivery device.
20. The method of claim 15 wherein the vascular abnormality comprises facial telangiectasia.
21. The method of claim 15 further comprising providing an alexandrite laser source to provide the beam of radiation having a wavelength at about 755 nm.
22. A method of treating a pigmentary abnormality disposed in an epidermal region and a vascular abnormality disposed in a dermal region on a patient's face, comprising:
providing a beam of radiation having a wavelength between about 700 nm and about 800 nm, a fluence of between about 80 J/cm 2 and about 100 J/cm 2 , and a pulse duration between about 20 msec and about 60 msec;
delivering, during a single pass of a delivery device, the beam of radiation to a target region of skin of the patient's face to affect (i) at least one pigmentary abnormality disposed in the epidermal region of the target region and (ii) at least one vascular abnormality disposed in the dermal region of the target region; and
cooling a surface of the epidermal region of the target region of skin.
23. The method of claim 22 further comprising providing a dynamic cooling device to cool the epidermal region of the target region of skin.
24. The method of claim 22 wherein at least one pigmentary abnormality and at least one vascular abnormality are treated substantially simultaneously.
25. The method of claim 22 further comprising positioning, over the target region of skin, a delivery device capable of directing the beam of radiation to the target region of skin.
26. The method of claim 25 further comprising traversing the beam of radiation along the surface of the target region of skin to treat the at least one vascular abnormality and the at least one pigmentary abnormality during a single pass of the delivery device.
27. The method of claim 25 further comprising providing an alexandrite laser source to provide the beam of radiation having a wavelength at about 755 nm.